High seroprotection rates among adults 10 years after inactivated Vero cell-derived Japanese encephalitis vaccine, IXIARO
Japanese encephalitis (JE), a mosquito-borne, vaccine-preventable disease, is a risk in parts of Asia and Oceania. A previous study showed that after a primary 2-dose series and booster dose of the Vero cell-derived JE vaccine (JE-VC; IXIARO), high seroprotection rates in adults persisted through 6 years. We used ser...